HK1 Gene - Hexokinase 1

Key regulator of glucose metabolism and erythroid development

Gene Information Card

Symbol HK1
Full Name Hexokinase 1
Gene Type Protein coding
Chromosomal Location 10q22.1
NCBI Gene ID 3098 ncbi.nlm.nih.gov/gene/3098
Ensembl ID ENSG00000156515
UniProt ID P19367
OMIM ID 142600
HGNC ID 4922
Aliases HK1-ta, HK1-tb, HK1-tc, HKD, HXK1, hexokinase type I

Description

HK1 encodes hexokinase 1, the first enzyme in glycolysis that phosphorylates glucose to glucose-6-phosphate. It is ubiquitously expressed, with highest levels in brain, erythrocytes, and kidney. The enzyme is allosterically inhibited by glucose-6-phosphate and plays a critical role in cellular energy homeostasis. Mutations in HK1 are associated with hemolytic anemia due to hexokinase deficiency and Charcot-Marie-Tooth disease type 4G (CMT4G).

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hemolytic anemia due to hexokinase deficiency Loss-of-function mutations reduce enzyme activity, impairing erythrocyte glycolysis and ATP production, leading to premature red cell destruction OMIM #235700; ClinVar
Charcot-Marie-Tooth disease type 4G (CMT4G) Missense mutations cause dominant-negative or gain-of-function effects, disrupting peripheral nerve myelination and axonal function OMIM #605285; ClinVar
Retinitis pigmentosa (rare association) Altered glucose metabolism in retinal cells due to HK1 deficiency OMIM #268000; NCBI GeneReviews

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 28.5 High
Erythrocytes 22.1 High
Kidney 18.3 Medium
Liver 12.7 Medium
Skeletal muscle 8.9 Low
Cell Line Expression
Cell Line nTPM Notes
K-562 (erythroleukemia) 35.2 High expression
HEK293 (embryonic kidney) 20.1 Moderate expression
SH-SY5Y (neuroblastoma) 25.6 High expression
HepG2 (hepatocellular carcinoma) 15.4 Moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1439G>A (p.Arg480His) Missense <0.01% Reduced enzyme activity; associated with hemolytic anemia
c.1A>G (p.Met1Val) Start loss <0.01% Complete loss of function; severe hemolytic anemia
c.242C>T (p.Thr81Met) Missense <0.01% Dominant-negative; associated with CMT4G
c.1034T>C (p.Leu345Pro) Missense <0.01% Gain-of-function; linked to neuropathy
Mutation functional classification

Loss of Function (LOF)

Most common; missense or nonsense mutations reduce or abolish hexokinase activity, leading to hemolytic anemia.

Gain of Function (GOF)

Rare; specific missense mutations (e.g., p.Leu345Pro) increase enzyme activity, associated with Charcot-Marie-Tooth disease.

Dominant Negative (DN)

Mutations such as p.Thr81Met interfere with wild-type enzyme function, causing neuropathy.

Pathways

Glycolysis / Gluconeogenesis (KEGG: hsa00010)
Pentose phosphate pathway (KEGG: hsa00030)
Insulin signaling pathway (KEGG: hsa04910)

Protein Summary

Hexokinase 1 is a 100 kDa enzyme that catalyzes the first committed step of glycolysis. It exists in multiple isoforms generated by alternative splicing. The protein has two homologous domains, with the catalytic site in the C-terminal domain. It binds to the outer mitochondrial membrane via a porin-binding domain, coupling glycolysis to oxidative phosphorylation. HK1 is essential for erythrocyte survival and neuronal energy metabolism.

Related Products

Product name Cat.No. Species Gene ID
SPHK1 Knockout HEK293 Cell Line EDJ-KQ1066 Human 8877 Details Get a Quote
HK1 Knockout HEK293 Cell Line EDJ-KQ1506 Human 3098 Details Get a Quote
SPHK1 Knockout A-549 Cell Line EDJ-KQ20196 Human 8877 Details Get a Quote
SPHK1 Knockout HCT 116 Cell Line EDJ-KQ20197 Human 8877 Details Get a Quote
HK1 Knockout A-549 Cell Line EDJ-KQ21124 Human 3098 Details Get a Quote
HK1 Knockout HCT 116 Cell Line EDJ-KQ21125 Human 3098 Details Get a Quote
HK1 Knockout HeLa Cell Line EDJ-KQ21126 Human 3098 Details Get a Quote
SPHK1 Knockout HeLa Cell Line EDJ-KQ18852 Human 8877 Details Get a Quote
Displaying Records 1 To 8 Of 8 Records
Contact Us
*
*
*
*
How did you hear about us: